Skip to main content

Biogen Inc. (NASDAQ: BIIB) Investor Securities Class Action Lawsuit 05/22/2024

  • If you purchased a significant amount of shares of Biogen Inc. (NASDAQ: BIIB) between February 3, 2022 and February 13, 2024, and / or if you purchased any NASDAQ: BIIB shares prior to February 2022 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: July 22, 2024. NASDAQ: BIIB investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

May 22, 2024 - An investor in shares of Biogen Inc. (NASDAQ: BIIB) filed a lawsuit in the U.S. District Court for the District of Colorado over alleged violations of Federal Securities Laws by Biogen Inc. in connection with certain allegedly false and misleading statements made between February 3, 2022 and February 13, 2024. Cambrdige, MA based Biogen Inc. discovers, develops, manufac...

You must register (for free) or login to view the entire case.